Articles On Avita Medical (ASX:AVH)

Shares in the spray-on skin company Avita Medical Inc (ASX: AVH) closed 2.6% higher on Friday at $1.96. The ASX healthcare share may be down 42% over the year to date, but it appears to be making a comeback. The Avita share price is up a...

Ask A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Bell Direct market analyst Grady Wulff names two cheap ASX shares to buy and one to ho...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

A global relief rally catapulted the ASX 200 to a five-month high after Wall Street celebrated a slowdown in inflation with its biggest advance since 2020. The S&P/ASX 200 wrapped up a strong week with a rise of 194 points or 2.79 pe...

ASX health stocks extend weekly gains on Friday as markets rally on back of promising US inflation figures Wound care company Avita rises 24% and biotech Antisense is up 18% for past five days Fertility company Monash IVF provides solid H1...

Avita Medical (AVH) reports a 30-per-cent bump to year-on-year revenue over the September quarter of this yearOver the three-month period, the company posted $9 million in quarterly commercial revenue compared to just under $7 million over...

Wall Street’s best night since 2020 fuelled strong gains on the ASX, powering the benchmark to its highest level since June. The S&P/ASX 200 rallied 163 points or 2.33 per cent by mid-session. The rally followed huge gains in the US...

Cynata gets Notice of Allowance from US Patent Office Proteomics secures patent in Hong Kong Ramsay Healthcare and Avita gave solid quarterly updates Cynata and Proteomics’ patents update Cynata Therapeutics (ASX:CYP) rose 8pc this mornin...

Highlights Australian shares opened higher on Friday. The ASX 200 gained in the opening trade, rising 36.10 points, or 0.52%, to 7,000.10. On Thursday, the benchmark index ended 0.5% higher at 6,964 points. Australian...

Avita Medical successfully achieved two co-primary endpoints Noxopharm received $5.011 million in R&D rebate Avita makes crucial progress in pivotal trial Avita Medical (ASX:AVH) announced that it has achieved the co-primary endpoints...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Analysts at Wilsons have put the spotlight on one All Ordinaries Index (ASX: XAO) share it prefers over the Polynovo Ltd (ASX: PNV) share price. Polynovo shares fell 3.23% today to $1.98. For perspective, the All Ordinaries Index climbed...

Franklin Templeton says innovation accelerates despite recessions, pandemic, wars Expect advancements in sectors like gene therapy and augmented reality in healthcare New ways to grab our attention are reinventing the media industry Frank...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Regenerative medicine company AVITA Medical (AVH) appoints James Corbett as CEO, effective immediatelyMr Corbett has almost 40 years of experience in the life sciences field and has extensive global, operational and commercial experience He...

The S&P/ASX All Ordinaries Index (ASX: XAO) is deep in the red today after a hot US inflation report sent Wall Street into a tailspin overnight. At the time of writing, the All Ords index has slipped 2.6% to 7,065 points. The S&P/A...

Local markets set to open higher, Friday Late rally sees the S&P 500 close ahead, first time in five days  US China trade war flares as chipmaker banned  Local shares are set to open higher on Friday. At 8am AEST, the ASX 200 Septembe...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. ASX health sector modestly up...

Regenerative medicine company AVITA Medical (ASX:AVH) has announced topline results from its pivotal trial evaluating the safety and effectiveness of the RECELL System combined with meshed autograft for reduction of donor skin harve...

By Greg Peel Just a Scare Wall Street had shot up initially on a lower PPI print on Thursday night before rolling over to close flat, suggesting maybe the comeback rally had run its course. The local market thus ran scared from the open, dr...

The benchmark grumbles to a slovenly 0.7% slide Aussie bond yields have risen 13 basis points as recession chatter continues Domino’s sinks after getting laughed out of Italy The ASX has been consistently indolent, even – dare we say it –...

The share market secured its longest weekly winning streak in more than a year after weathering profit-taking today after Wall Street’s “peak-inflation” relief rally ran out of gas. The S&P/ASX 200 eked out a fourth week of gains. A...

The share market came close to erasing its gains for the week following soft leads from Wall Street and a bout of profit-taking at two-month highs. The S&P/ASX 200 remained on track for a fourth week of gains despite falling 42 point...

Avita Medical’s top line results on RECELL disappoint investors Cynata has completed a strategic review, and will terminate its Covid-19 study Resmed’s revenue grows in FY22 Shares in regenerative cells biotech Avita Medical (ASX:AVH) plu...

The AVITA Medical Inc (ASX: AVH) share price is falling on the back of the company’s financial results. The medical technology company’s share price is currently $1.895, a 16.5% fall. For perspective, the S&P/ASX 200 Index (ASX...

AVITA Medical (AVH) reports positive top line results for its RECELL trial in patients with soft-tissue injuries The company released results from its randomised, controlled trial which evaluated the effectiveness of the RECELL system when...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 will open lower on Friday Wall Street fades away late in the trading day Bitcoin has rallied further Local shares are set to open lower today. At 8am AEST, the ASX 200 August futures contract is pointing down by 0.35%. Overnig...

Aussie stocks were set to open sharply higher after inflation slowed more than expected in the US, easing pressure on the Federal Reserve to raise rates aggressively. A relief rally lifted two of Wall Street’s three main indices by more...

Aussie stocks were poised for a cautious start to the week following a mixed close in the US after blowout jobs figures dashed hopes of a slowdown in interest rate hikes.   Surging bond yields helped drive the S&P 500 and Nasdaq Comp...

The ASX 200 is down, the XEC surged late, up 1.5%  Tech stocks rise, Cons discretionary and energy dragging US Futures flat, Chinese markets higher on Pelosi goes to Taipei day   Ahead of the close here in Sydney, US Futures connected to...

The Polynovo Ltd (ASX: PNV) share price is trading in the green during the afternoon session on Wednesday. At the time of writing, shares in the medical devices company are trading 6.33% higher at $1.68 apiece. Earlier this afternoon, t...

The AVITA Medical Inc (ASX: AVH) share price has shot well into the green in lunchtime trade on Wednesday. At the time of writing, the company’s shares are 19.88% higher at $2.05 apiece on no news. In broader market moves, the S&P...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. What happened Nasdaq I...

The Metalstech Ltd (ASX: MTC) share price is lifting into the green in early trade on Wednesday. At the time of writing, the gold and lithium explorer is trading around 11% higher at 40.5 cents apiece following the release of a company a...

The ASX Ltd (ASX: ASX) share price is in the red. Its tumble comes after the market operator announced that its long-awaited CHESS replacement likely won’t be operational until at least 2024. The company has also commissioned an independe...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. What happened Shares o...

What are the risks of investing in biotechs? How to value a biotech Top 10 crucial trials coming up for ASX biotechs in 2022 Risks of investing in biotechs Historical data shows that biotech is one the best sectors to put your money in ov...

This month I’ve been looking at a number of shares that Bell Potter has rated as its top picks for FY 2023. You can read about its tech picks here and its energy picks here. On this occasion, let’s take a look at a couple of ASX health...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Morningstar bullish on ability of ASX healthcare sector to come back S&P ASX 200 Health Care Index outperformed S&P ASX 200 by more than 8% in Q3FY22 Morningstar picks Avita Medical and Sigma Healthcare as two standouts Morningst...

Avita Medical makes spray on skin for burns and soft tissue injuries HITIQ’s concussion tech is popular for athletes and sports teams PainChek’s smartphone app can tell if babies or older Aussies are in pain There’s a plethora of biotech...

Regenerative medicine company AVITA Medical (ASX:AVH) has won the Australasian Investor Relations Association Award for Best Investor Relations by a company in the S&P/ASX Emerging Companies Index.

Avita Medical (AVH) reports a 14 per cent year-on-year decrease in net revenue to $7.5 million in the March quarter Despite this, commercial sales rose 61 per cent to $7.4 million, reflecting sales of its RECELL system which treats acute t...

The Avita Medical Inc (ASX: AVH) share price is down 7.2% to $1.62 in early trade. Avita focuses on regenerative medicines. Its spray-on Recell medicine is used to treat burn patients. Below we look at the ASX healthcare share’s first-quar...

The deep sell down of the US biotech sector has resulted in the valuation of many of the ASX-listed life science plays looking a tad sickly, too. Arguably, many of them were overvalued in the first place. But in many cases the companies ar...

Plenty of ASX healthcare shares fell to 52-week lows today. The industry has not been immune to the ASX share market selloff. There is ongoing volatility with investors keeping an on the Russian conflict with Ukraine, the sanctions and the...

As well as being home to countless blue chip shares, the Australian share market is home to a good number of promising small caps. Three small cap shares that could be worth adding to your watchlist are listed below. Here’s what you need t...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 Health Index (XHJ) is trading lower by 0.30% at the time of writing, compared to the broader index which is up by 0.90%. Regenerative medicine company, Avita Medical (ASX:AVH), has been awarded a purchasing contract from Premier...